University of Utah
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).
University of Utah: 818 sponsored US clinical trials, 138 recruiting.
University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.
Top-decile sponsor footprint
University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
818 total, page 5 of 17
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)
NCT07573436
Optimizing Pregnancy and Treatment Interventions for Moms 3.0
NCT07586917
SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier
NCT07460440
Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
NCT07548450
Supplemental Oxygen and Oxygen Desaturations in Colonoscopies
NCT07515755
Decreasing Nightmares in Adults With Narcolepsy
NCT06383806
Economic Empowerment and Health Promotion of Uganda Grandmother-caregivers.
NCT07011264
Hormonal Influences on Inflammatory Bowel Diseases
NCT05610527
PREVENT Pilot HPV - Related Cancers Trial
NCT06738355
Social Media and Cancer Screening Information
NCT06712901
Hydrus Learning Curve Study
NCT06964139
Sun Protection and Tanning Awareness in Rural Schools
NCT06694571
Family-Based Meal Timing for Cancer Prevention Among Native Hawaiian and Other Pacific Islanders: FAMTIME
NCT07262593
Participatory Research for Suicide Prevention in Autism
NCT06552871
Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions
NCT06558838
Ultrasonic Neuromodulation for Treatment of Cognitive Impairment
NCT06135051
Low-Cost Platelet-Rich Plasma for Hemarthropathy
NCT06543368
EUREKA: Evaluating Ultraviolet Radiation Exposure in Kids for Adaptive Intervention
NCT07204704
A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients
NCT06002269
Ultrasonic Neuromodulation for Treatment of PTSD
NCT06135064
Intra-articular Platelet-Rich Plasma for Acetabular Labral Tears
NCT06332352
PREVENT HPV-Related Cancers - BootCamp Translation
NCT06290206
Feasibility and Acceptability Study of ACUAWARE
NCT06145997
Evaluating Online Messages About Colon Cancer Screening
NCT06134089
Pilot Feasibility Study of a Novel Non-invasive Device for Diagnosis of Anemia
NCT06159348
Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers
NCT06001372
Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery
NCT06118957
Feasibility Study of Resistance Training Intervention in Untrained Adolescents
NCT06710691
Validation of a Low-cost Platelet-Rich Plasma (PRP)
NCT06184048
Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.
NCT06030297
A Novel Wearable Device to Improve Sleep Quality
NCT05952297
Diabetes Education and Care for Deaf Populations
NCT06577506
Siblings as Caregivers
NCT05937724
Physical Therapy Integrated With Mindfulness for Patients With Chronic Pain and Opioid Treatment
NCT05875207
Developing and Testing the Enhancing Active Caregiver Training (EnACT) Intervention for Dementia Family Caregivers
NCT04920006
Brief Mindfulness for Foot and Ankle Pain
NCT05939843
Deep Brain Therapy With Low-intensity Ultrasound for Generalized Chronic Pain
NCT05674903
Exercise Timing in Breast Cancer Patients
NCT05821244
Understanding Factors in Decision Making for Children With Medical Complexity
NCT05913206
Co-Use of Opioid Medications and Alcohol Prevention Study
NCT05599672
Improving Health Insurance Literacy Among Utah's Hispanic Population
NCT04823975
The Effectiveness of a Novel Software Program to Help in ROTEM Interpretation
NCT05591014
Real-Time Biofeedback on Partial Weightbearing Training
NCT06368778
Emotional Awareness and Expression Therapy (EAET) as a Novel Migraine Treatment
NCT05837650
Vancomycin and Tobramycin Powder Use in Acute Open Fractures
NCT05849090
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
NCT05614115
Emotional Awareness and Expression Therapy (EAET) for Migraine
NCT05755698
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence
NCT05634005
SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study
NCT05533359
Medrol Dose Packs for Post-Operative Pain Control
NCT06453083
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 145 |
| Phase 2 | 123 |
| Phase 3 | 18 |
| Phase 4 | 27 |
Therapeutic Areas
What is open in the University of Utah pipeline
138 recruiting of 818 indexed (17% open); 492 completed (60%).
Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).
Top condition: Low Back Pain (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Utah: open-pipeline peers nationwide
Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 818 trials (± recruiting share)
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
Sponsors near 17% open enrollment (± trial volume)
- University of Hawaii · 17% recruiting · 77 trials
- Penn State University · 17% recruiting · 219 trials
- AdventHealth · 17% recruiting · 95 trials
- CSL Behring · 17% recruiting · 71 trials
Related
What to do with this University of Utah page
818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.
- 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Utah pipeline card: 818 registered trials from official public datasets.Report a data error.